nodes	percent_of_prediction	percent_of_DWPC	metapath
Phenylephrine—Isoprenaline—MAPK1—multiple sclerosis	0.00943	0.341	CrCbGaD
Phenylephrine—Edrophonium—BCHE—multiple sclerosis	0.00908	0.329	CrCbGaD
Phenylephrine—Terbutaline—BCHE—multiple sclerosis	0.00688	0.249	CrCbGaD
Phenylephrine—Visual disturbance—Prednisolone—multiple sclerosis	0.0025	0.00285	CcSEcCtD
Phenylephrine—Sweating increased—Mitoxantrone—multiple sclerosis	0.00243	0.00277	CcSEcCtD
Phenylephrine—Pulmonary oedema—Betamethasone—multiple sclerosis	0.00243	0.00277	CcSEcCtD
Phenylephrine—Pulmonary oedema—Dexamethasone—multiple sclerosis	0.00243	0.00277	CcSEcCtD
Phenylephrine—Headache—Fingolimod—multiple sclerosis	0.00239	0.00272	CcSEcCtD
Phenylephrine—Extravasation—Methotrexate—multiple sclerosis	0.00228	0.00259	CcSEcCtD
Phenylephrine—Skin exfoliation—Prednisone—multiple sclerosis	0.00227	0.00258	CcSEcCtD
Phenylephrine—Chest pain—Cladribine—multiple sclerosis	0.00226	0.00257	CcSEcCtD
Phenylephrine—Epinephrine—TNF—multiple sclerosis	0.00224	0.0811	CrCbGaD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Cladribine—multiple sclerosis	0.00224	0.00255	CcSEcCtD
Phenylephrine—Immune system disorder—Azathioprine—multiple sclerosis	0.00224	0.00255	CcSEcCtD
Phenylephrine—Mediastinal disorder—Azathioprine—multiple sclerosis	0.00223	0.00254	CcSEcCtD
Phenylephrine—Arrhythmia—Azathioprine—multiple sclerosis	0.00221	0.00252	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Mitoxantrone—multiple sclerosis	0.0022	0.0025	CcSEcCtD
Phenylephrine—Eye pain—Betamethasone—multiple sclerosis	0.00219	0.0025	CcSEcCtD
Phenylephrine—Eye pain—Dexamethasone—multiple sclerosis	0.00219	0.0025	CcSEcCtD
Phenylephrine—Myocardial infarction—Mitoxantrone—multiple sclerosis	0.00218	0.00249	CcSEcCtD
Phenylephrine—Nervous system disorder—Cladribine—multiple sclerosis	0.00212	0.00242	CcSEcCtD
Phenylephrine—Pulmonary oedema—Prednisone—multiple sclerosis	0.00211	0.00241	CcSEcCtD
Phenylephrine—Tachycardia—Cladribine—multiple sclerosis	0.00211	0.00241	CcSEcCtD
Phenylephrine—Skin disorder—Cladribine—multiple sclerosis	0.0021	0.00239	CcSEcCtD
Phenylephrine—Hyperhidrosis—Cladribine—multiple sclerosis	0.00209	0.00238	CcSEcCtD
Phenylephrine—Visual disturbance—Dexamethasone—multiple sclerosis	0.00209	0.00238	CcSEcCtD
Phenylephrine—Visual disturbance—Betamethasone—multiple sclerosis	0.00209	0.00238	CcSEcCtD
Phenylephrine—Bradycardia—Mitoxantrone—multiple sclerosis	0.00204	0.00232	CcSEcCtD
Phenylephrine—Sweating increased—Prednisolone—multiple sclerosis	0.002	0.00228	CcSEcCtD
Phenylephrine—Paraesthesia—Cladribine—multiple sclerosis	0.00194	0.00221	CcSEcCtD
Phenylephrine—Dyspnoea—Cladribine—multiple sclerosis	0.00193	0.0022	CcSEcCtD
Phenylephrine—Skin exfoliation—Methotrexate—multiple sclerosis	0.0019	0.00216	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Cladribine—multiple sclerosis	0.00187	0.00213	CcSEcCtD
Phenylephrine—Pain—Cladribine—multiple sclerosis	0.00185	0.00211	CcSEcCtD
Phenylephrine—Sweating increased—Triamcinolone—multiple sclerosis	0.00184	0.00209	CcSEcCtD
Phenylephrine—Sweating increased—Methylprednisolone—multiple sclerosis	0.00183	0.00209	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—multiple sclerosis	0.00182	0.00208	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Prednisolone—multiple sclerosis	0.0018	0.00205	CcSEcCtD
Phenylephrine—Myocardial infarction—Prednisolone—multiple sclerosis	0.00179	0.00204	CcSEcCtD
Phenylephrine—Arrhythmia—Mitoxantrone—multiple sclerosis	0.00179	0.00204	CcSEcCtD
Phenylephrine—Pulmonary oedema—Methotrexate—multiple sclerosis	0.00177	0.00201	CcSEcCtD
Phenylephrine—Urticaria—Cladribine—multiple sclerosis	0.00172	0.00196	CcSEcCtD
Phenylephrine—Skin disorder—Azathioprine—multiple sclerosis	0.00171	0.00195	CcSEcCtD
Phenylephrine—Dysgeusia—Mitoxantrone—multiple sclerosis	0.00171	0.00194	CcSEcCtD
Phenylephrine—Bradycardia—Prednisolone—multiple sclerosis	0.00167	0.0019	CcSEcCtD
Phenylephrine—Sweating increased—Dexamethasone—multiple sclerosis	0.00167	0.0019	CcSEcCtD
Phenylephrine—Sweating increased—Betamethasone—multiple sclerosis	0.00167	0.0019	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Triamcinolone—multiple sclerosis	0.00166	0.00189	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Methylprednisolone—multiple sclerosis	0.00165	0.00188	CcSEcCtD
Phenylephrine—Myocardial infarction—Triamcinolone—multiple sclerosis	0.00165	0.00188	CcSEcCtD
Phenylephrine—Myocardial infarction—Methylprednisolone—multiple sclerosis	0.00164	0.00187	CcSEcCtD
Phenylephrine—Vision blurred—Mitoxantrone—multiple sclerosis	0.00164	0.00187	CcSEcCtD
Phenylephrine—Hypersensitivity—Cladribine—multiple sclerosis	0.00159	0.00182	CcSEcCtD
Phenylephrine—Visual impairment—Prednisolone—multiple sclerosis	0.00158	0.0018	CcSEcCtD
Phenylephrine—Bradycardia—Triamcinolone—multiple sclerosis	0.00154	0.00175	CcSEcCtD
Phenylephrine—Bradycardia—Methylprednisolone—multiple sclerosis	0.00153	0.00175	CcSEcCtD
Phenylephrine—Pruritus—Cladribine—multiple sclerosis	0.00153	0.00174	CcSEcCtD
Phenylephrine—Visual disturbance—Methotrexate—multiple sclerosis	0.00152	0.00173	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Azathioprine—multiple sclerosis	0.00152	0.00173	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Betamethasone—multiple sclerosis	0.0015	0.00171	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Dexamethasone—multiple sclerosis	0.0015	0.00171	CcSEcCtD
Phenylephrine—Hypertension—Mitoxantrone—multiple sclerosis	0.0015	0.00171	CcSEcCtD
Phenylephrine—Myocardial infarction—Dexamethasone—multiple sclerosis	0.0015	0.0017	CcSEcCtD
Phenylephrine—Myocardial infarction—Betamethasone—multiple sclerosis	0.0015	0.0017	CcSEcCtD
Phenylephrine—Chest pain—Mitoxantrone—multiple sclerosis	0.00148	0.00169	CcSEcCtD
Phenylephrine—Arrhythmia—Prednisolone—multiple sclerosis	0.00147	0.00167	CcSEcCtD
Phenylephrine—Sweating increased—Prednisone—multiple sclerosis	0.00145	0.00165	CcSEcCtD
Phenylephrine—Visual impairment—Methylprednisolone—multiple sclerosis	0.00145	0.00165	CcSEcCtD
Phenylephrine—Dizziness—Cladribine—multiple sclerosis	0.00143	0.00163	CcSEcCtD
Phenylephrine—Shock—Mitoxantrone—multiple sclerosis	0.0014	0.00159	CcSEcCtD
Phenylephrine—Cardiac disorder—Methylprednisolone—multiple sclerosis	0.0014	0.00159	CcSEcCtD
Phenylephrine—Bradycardia—Dexamethasone—multiple sclerosis	0.00139	0.00159	CcSEcCtD
Phenylephrine—Bradycardia—Betamethasone—multiple sclerosis	0.00139	0.00159	CcSEcCtD
Phenylephrine—Tachycardia—Mitoxantrone—multiple sclerosis	0.00139	0.00158	CcSEcCtD
Phenylephrine—Skin disorder—Mitoxantrone—multiple sclerosis	0.00138	0.00157	CcSEcCtD
Phenylephrine—Vomiting—Cladribine—multiple sclerosis	0.00137	0.00157	CcSEcCtD
Phenylephrine—Hyperhidrosis—Mitoxantrone—multiple sclerosis	0.00137	0.00157	CcSEcCtD
Phenylephrine—Angiopathy—Methylprednisolone—multiple sclerosis	0.00137	0.00156	CcSEcCtD
Phenylephrine—Rash—Cladribine—multiple sclerosis	0.00136	0.00155	CcSEcCtD
Phenylephrine—Dermatitis—Cladribine—multiple sclerosis	0.00136	0.00155	CcSEcCtD
Phenylephrine—Immune system disorder—Methylprednisolone—multiple sclerosis	0.00136	0.00155	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methylprednisolone—multiple sclerosis	0.00136	0.00155	CcSEcCtD
Phenylephrine—Headache—Cladribine—multiple sclerosis	0.00135	0.00154	CcSEcCtD
Phenylephrine—Arrhythmia—Triamcinolone—multiple sclerosis	0.00135	0.00154	CcSEcCtD
Phenylephrine—Vision blurred—Prednisolone—multiple sclerosis	0.00135	0.00153	CcSEcCtD
Phenylephrine—Arrhythmia—Methylprednisolone—multiple sclerosis	0.00135	0.00153	CcSEcCtD
Phenylephrine—Visual impairment—Dexamethasone—multiple sclerosis	0.00132	0.0015	CcSEcCtD
Phenylephrine—Visual impairment—Betamethasone—multiple sclerosis	0.00132	0.0015	CcSEcCtD
Phenylephrine—Mental disorder—Methylprednisolone—multiple sclerosis	0.00132	0.0015	CcSEcCtD
Phenylephrine—Acute coronary syndrome—Prednisone—multiple sclerosis	0.00131	0.00149	CcSEcCtD
Phenylephrine—Myocardial infarction—Prednisone—multiple sclerosis	0.0013	0.00148	CcSEcCtD
Phenylephrine—Hypersensitivity—Azathioprine—multiple sclerosis	0.0013	0.00148	CcSEcCtD
Phenylephrine—Dysgeusia—Triamcinolone—multiple sclerosis	0.00129	0.00147	CcSEcCtD
Phenylephrine—Nausea—Cladribine—multiple sclerosis	0.00128	0.00146	CcSEcCtD
Phenylephrine—Syncope—Prednisolone—multiple sclerosis	0.00128	0.00146	CcSEcCtD
Phenylephrine—Paraesthesia—Mitoxantrone—multiple sclerosis	0.00128	0.00145	CcSEcCtD
Phenylephrine—Dyspnoea—Mitoxantrone—multiple sclerosis	0.00127	0.00144	CcSEcCtD
Phenylephrine—Loss of consciousness—Prednisolone—multiple sclerosis	0.00126	0.00143	CcSEcCtD
Phenylephrine—Angiopathy—Dexamethasone—multiple sclerosis	0.00124	0.00142	CcSEcCtD
Phenylephrine—Angiopathy—Betamethasone—multiple sclerosis	0.00124	0.00142	CcSEcCtD
Phenylephrine—Hypertension—Prednisolone—multiple sclerosis	0.00123	0.00141	CcSEcCtD
Phenylephrine—Arrhythmia—Dexamethasone—multiple sclerosis	0.00122	0.00139	CcSEcCtD
Phenylephrine—Arrhythmia—Betamethasone—multiple sclerosis	0.00122	0.00139	CcSEcCtD
Phenylephrine—Pain—Mitoxantrone—multiple sclerosis	0.00122	0.00139	CcSEcCtD
Phenylephrine—Bradycardia—Prednisone—multiple sclerosis	0.00121	0.00138	CcSEcCtD
Phenylephrine—Syncope—Triamcinolone—multiple sclerosis	0.00118	0.00134	CcSEcCtD
Phenylephrine—Syncope—Methylprednisolone—multiple sclerosis	0.00118	0.00134	CcSEcCtD
Phenylephrine—Dizziness—Azathioprine—multiple sclerosis	0.00116	0.00133	CcSEcCtD
Phenylephrine—Loss of consciousness—Triamcinolone—multiple sclerosis	0.00115	0.00132	CcSEcCtD
Phenylephrine—Loss of consciousness—Methylprednisolone—multiple sclerosis	0.00115	0.00131	CcSEcCtD
Phenylephrine—Shock—Prednisolone—multiple sclerosis	0.00115	0.00131	CcSEcCtD
Phenylephrine—Tachycardia—Prednisolone—multiple sclerosis	0.00114	0.0013	CcSEcCtD
Phenylephrine—Hypertension—Triamcinolone—multiple sclerosis	0.00113	0.00129	CcSEcCtD
Phenylephrine—Hypertension—Methylprednisolone—multiple sclerosis	0.00113	0.00129	CcSEcCtD
Phenylephrine—Urticaria—Mitoxantrone—multiple sclerosis	0.00113	0.00129	CcSEcCtD
Phenylephrine—Hyperhidrosis—Prednisolone—multiple sclerosis	0.00113	0.00128	CcSEcCtD
Phenylephrine—Vomiting—Azathioprine—multiple sclerosis	0.00112	0.00127	CcSEcCtD
Phenylephrine—Rash—Azathioprine—multiple sclerosis	0.00111	0.00126	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—multiple sclerosis	0.00111	0.00126	CcSEcCtD
Phenylephrine—Dermatitis—Azathioprine—multiple sclerosis	0.00111	0.00126	CcSEcCtD
Phenylephrine—Headache—Azathioprine—multiple sclerosis	0.0011	0.00126	CcSEcCtD
Phenylephrine—Angiopathy—Prednisone—multiple sclerosis	0.00108	0.00123	CcSEcCtD
Phenylephrine—Immune system disorder—Prednisone—multiple sclerosis	0.00108	0.00123	CcSEcCtD
Phenylephrine—Syncope—Dexamethasone—multiple sclerosis	0.00107	0.00122	CcSEcCtD
Phenylephrine—Syncope—Betamethasone—multiple sclerosis	0.00107	0.00122	CcSEcCtD
Phenylephrine—Arrhythmia—Prednisone—multiple sclerosis	0.00107	0.00121	CcSEcCtD
Phenylephrine—Shock—Triamcinolone—multiple sclerosis	0.00106	0.0012	CcSEcCtD
Phenylephrine—Shock—Methylprednisolone—multiple sclerosis	0.00105	0.0012	CcSEcCtD
Phenylephrine—Nervous system disorder—Methylprednisolone—multiple sclerosis	0.00105	0.0012	CcSEcCtD
Phenylephrine—Loss of consciousness—Dexamethasone—multiple sclerosis	0.00105	0.00119	CcSEcCtD
Phenylephrine—Loss of consciousness—Betamethasone—multiple sclerosis	0.00105	0.00119	CcSEcCtD
Phenylephrine—Hypersensitivity—Mitoxantrone—multiple sclerosis	0.00105	0.00119	CcSEcCtD
Phenylephrine—Paraesthesia—Prednisolone—multiple sclerosis	0.00105	0.00119	CcSEcCtD
Phenylephrine—Tachycardia—Triamcinolone—multiple sclerosis	0.00105	0.00119	CcSEcCtD
Phenylephrine—Mental disorder—Prednisone—multiple sclerosis	0.00104	0.00119	CcSEcCtD
Phenylephrine—Nausea—Azathioprine—multiple sclerosis	0.00104	0.00119	CcSEcCtD
Phenylephrine—Tachycardia—Methylprednisolone—multiple sclerosis	0.00104	0.00119	CcSEcCtD
Phenylephrine—Skin disorder—Methylprednisolone—multiple sclerosis	0.00104	0.00118	CcSEcCtD
Phenylephrine—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.00104	0.00118	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.00103	0.00118	CcSEcCtD
Phenylephrine—Hypertension—Betamethasone—multiple sclerosis	0.00103	0.00117	CcSEcCtD
Phenylephrine—Hypertension—Dexamethasone—multiple sclerosis	0.00103	0.00117	CcSEcCtD
Phenylephrine—Pain—Prednisolone—multiple sclerosis	0.000997	0.00114	CcSEcCtD
Phenylephrine—Vision blurred—Prednisone—multiple sclerosis	0.000979	0.00112	CcSEcCtD
Phenylephrine—Paraesthesia—Triamcinolone—multiple sclerosis	0.000963	0.0011	CcSEcCtD
Phenylephrine—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000961	0.0011	CcSEcCtD
Phenylephrine—Visual impairment—Methotrexate—multiple sclerosis	0.000961	0.00109	CcSEcCtD
Phenylephrine—Shock—Dexamethasone—multiple sclerosis	0.000957	0.00109	CcSEcCtD
Phenylephrine—Shock—Betamethasone—multiple sclerosis	0.000957	0.00109	CcSEcCtD
Phenylephrine—Dyspnoea—Triamcinolone—multiple sclerosis	0.000956	0.00109	CcSEcCtD
Phenylephrine—Nervous system disorder—Dexamethasone—multiple sclerosis	0.000954	0.00109	CcSEcCtD
Phenylephrine—Nervous system disorder—Betamethasone—multiple sclerosis	0.000954	0.00109	CcSEcCtD
Phenylephrine—Agitation—Prednisone—multiple sclerosis	0.000954	0.00109	CcSEcCtD
Phenylephrine—Tachycardia—Dexamethasone—multiple sclerosis	0.00095	0.00108	CcSEcCtD
Phenylephrine—Tachycardia—Betamethasone—multiple sclerosis	0.00095	0.00108	CcSEcCtD
Phenylephrine—Hyperhidrosis—Betamethasone—multiple sclerosis	0.000941	0.00107	CcSEcCtD
Phenylephrine—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.000941	0.00107	CcSEcCtD
Phenylephrine—Syncope—Prednisone—multiple sclerosis	0.000931	0.00106	CcSEcCtD
Phenylephrine—Urticaria—Prednisolone—multiple sclerosis	0.000926	0.00106	CcSEcCtD
Phenylephrine—Cardiac disorder—Methotrexate—multiple sclerosis	0.000925	0.00105	CcSEcCtD
Phenylephrine—Pain—Triamcinolone—multiple sclerosis	0.000917	0.00105	CcSEcCtD
Phenylephrine—Loss of consciousness—Prednisone—multiple sclerosis	0.000913	0.00104	CcSEcCtD
Phenylephrine—Angiopathy—Methotrexate—multiple sclerosis	0.000904	0.00103	CcSEcCtD
Phenylephrine—Vomiting—Mitoxantrone—multiple sclerosis	0.000904	0.00103	CcSEcCtD
Phenylephrine—Immune system disorder—Methotrexate—multiple sclerosis	0.0009	0.00103	CcSEcCtD
Phenylephrine—Mediastinal disorder—Methotrexate—multiple sclerosis	0.000898	0.00102	CcSEcCtD
Phenylephrine—Hypertension—Prednisone—multiple sclerosis	0.000896	0.00102	CcSEcCtD
Phenylephrine—Rash—Mitoxantrone—multiple sclerosis	0.000896	0.00102	CcSEcCtD
Phenylephrine—Dermatitis—Mitoxantrone—multiple sclerosis	0.000895	0.00102	CcSEcCtD
Phenylephrine—Headache—Mitoxantrone—multiple sclerosis	0.00089	0.00101	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—multiple sclerosis	0.000878	0.001	CcSEcCtD
Phenylephrine—Paraesthesia—Betamethasone—multiple sclerosis	0.000874	0.000996	CcSEcCtD
Phenylephrine—Paraesthesia—Dexamethasone—multiple sclerosis	0.000874	0.000996	CcSEcCtD
Phenylephrine—Mental disorder—Methotrexate—multiple sclerosis	0.000873	0.000995	CcSEcCtD
Phenylephrine—Hypersensitivity—Prednisolone—multiple sclerosis	0.000859	0.000979	CcSEcCtD
Phenylephrine—Urticaria—Triamcinolone—multiple sclerosis	0.000852	0.000971	CcSEcCtD
Phenylephrine—Urticaria—Methylprednisolone—multiple sclerosis	0.00085	0.000969	CcSEcCtD
Phenylephrine—Dysgeusia—Methotrexate—multiple sclerosis	0.00085	0.000968	CcSEcCtD
Phenylephrine—Nausea—Mitoxantrone—multiple sclerosis	0.000844	0.000962	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Betamethasone—multiple sclerosis	0.00084	0.000957	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Dexamethasone—multiple sclerosis	0.00084	0.000957	CcSEcCtD
Phenylephrine—Shock—Prednisone—multiple sclerosis	0.000834	0.00095	CcSEcCtD
Phenylephrine—Pain—Betamethasone—multiple sclerosis	0.000832	0.000948	CcSEcCtD
Phenylephrine—Pain—Dexamethasone—multiple sclerosis	0.000832	0.000948	CcSEcCtD
Phenylephrine—Nervous system disorder—Prednisone—multiple sclerosis	0.000831	0.000947	CcSEcCtD
Phenylephrine—Tachycardia—Prednisone—multiple sclerosis	0.000827	0.000943	CcSEcCtD
Phenylephrine—Skin disorder—Prednisone—multiple sclerosis	0.000823	0.000938	CcSEcCtD
Phenylephrine—Hyperhidrosis—Prednisone—multiple sclerosis	0.000819	0.000934	CcSEcCtD
Phenylephrine—Vision blurred—Methotrexate—multiple sclerosis	0.000818	0.000932	CcSEcCtD
Phenylephrine—Hypersensitivity—Triamcinolone—multiple sclerosis	0.00079	0.0009	CcSEcCtD
Phenylephrine—Hypersensitivity—Methylprednisolone—multiple sclerosis	0.000788	0.000898	CcSEcCtD
Phenylephrine—Urticaria—Betamethasone—multiple sclerosis	0.000773	0.000881	CcSEcCtD
Phenylephrine—Urticaria—Dexamethasone—multiple sclerosis	0.000773	0.000881	CcSEcCtD
Phenylephrine—Dizziness—Prednisolone—multiple sclerosis	0.000771	0.000879	CcSEcCtD
Phenylephrine—Paraesthesia—Prednisone—multiple sclerosis	0.000761	0.000867	CcSEcCtD
Phenylephrine—Pruritus—Triamcinolone—multiple sclerosis	0.000759	0.000865	CcSEcCtD
Phenylephrine—Pruritus—Methylprednisolone—multiple sclerosis	0.000757	0.000863	CcSEcCtD
Phenylephrine—Chest pain—Methotrexate—multiple sclerosis	0.000739	0.000842	CcSEcCtD
Phenylephrine—Rash—Prednisolone—multiple sclerosis	0.000735	0.000838	CcSEcCtD
Phenylephrine—Dermatitis—Prednisolone—multiple sclerosis	0.000735	0.000837	CcSEcCtD
Phenylephrine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—multiple sclerosis	0.000734	0.000836	CcSEcCtD
Phenylephrine—Headache—Prednisolone—multiple sclerosis	0.000731	0.000833	CcSEcCtD
Phenylephrine—Dizziness—Triamcinolone—multiple sclerosis	0.000709	0.000808	CcSEcCtD
Phenylephrine—Dizziness—Methylprednisolone—multiple sclerosis	0.000708	0.000806	CcSEcCtD
Phenylephrine—Nervous system disorder—Methotrexate—multiple sclerosis	0.000694	0.000792	CcSEcCtD
Phenylephrine—Nausea—Prednisolone—multiple sclerosis	0.000693	0.000789	CcSEcCtD
Phenylephrine—Pruritus—Dexamethasone—multiple sclerosis	0.000688	0.000785	CcSEcCtD
Phenylephrine—Pruritus—Betamethasone—multiple sclerosis	0.000688	0.000785	CcSEcCtD
Phenylephrine—Skin disorder—Methotrexate—multiple sclerosis	0.000688	0.000784	CcSEcCtD
Phenylephrine—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000685	0.00078	CcSEcCtD
Phenylephrine—Vomiting—Triamcinolone—multiple sclerosis	0.000682	0.000777	CcSEcCtD
Phenylephrine—Vomiting—Methylprednisolone—multiple sclerosis	0.00068	0.000775	CcSEcCtD
Phenylephrine—Rash—Triamcinolone—multiple sclerosis	0.000676	0.000771	CcSEcCtD
Phenylephrine—Dermatitis—Triamcinolone—multiple sclerosis	0.000676	0.00077	CcSEcCtD
Phenylephrine—Rash—Methylprednisolone—multiple sclerosis	0.000675	0.000769	CcSEcCtD
Phenylephrine—Dermatitis—Methylprednisolone—multiple sclerosis	0.000674	0.000768	CcSEcCtD
Phenylephrine—Urticaria—Prednisone—multiple sclerosis	0.000673	0.000767	CcSEcCtD
Phenylephrine—Headache—Triamcinolone—multiple sclerosis	0.000672	0.000766	CcSEcCtD
Phenylephrine—Headache—Methylprednisolone—multiple sclerosis	0.00067	0.000764	CcSEcCtD
Phenylephrine—Dizziness—Dexamethasone—multiple sclerosis	0.000643	0.000733	CcSEcCtD
Phenylephrine—Dizziness—Betamethasone—multiple sclerosis	0.000643	0.000733	CcSEcCtD
Phenylephrine—Nausea—Triamcinolone—multiple sclerosis	0.000637	0.000726	CcSEcCtD
Phenylephrine—Paraesthesia—Methotrexate—multiple sclerosis	0.000636	0.000725	CcSEcCtD
Phenylephrine—Nausea—Methylprednisolone—multiple sclerosis	0.000636	0.000724	CcSEcCtD
Phenylephrine—Dyspnoea—Methotrexate—multiple sclerosis	0.000631	0.00072	CcSEcCtD
Phenylephrine—Hypersensitivity—Prednisone—multiple sclerosis	0.000624	0.000712	CcSEcCtD
Phenylephrine—Vomiting—Betamethasone—multiple sclerosis	0.000619	0.000705	CcSEcCtD
Phenylephrine—Vomiting—Dexamethasone—multiple sclerosis	0.000619	0.000705	CcSEcCtD
Phenylephrine—Rash—Betamethasone—multiple sclerosis	0.000614	0.000699	CcSEcCtD
Phenylephrine—Rash—Dexamethasone—multiple sclerosis	0.000614	0.000699	CcSEcCtD
Phenylephrine—Dermatitis—Betamethasone—multiple sclerosis	0.000613	0.000699	CcSEcCtD
Phenylephrine—Dermatitis—Dexamethasone—multiple sclerosis	0.000613	0.000699	CcSEcCtD
Phenylephrine—Gastrointestinal disorder—Methotrexate—multiple sclerosis	0.000611	0.000697	CcSEcCtD
Phenylephrine—Headache—Dexamethasone—multiple sclerosis	0.00061	0.000695	CcSEcCtD
Phenylephrine—Headache—Betamethasone—multiple sclerosis	0.00061	0.000695	CcSEcCtD
Phenylephrine—Pain—Methotrexate—multiple sclerosis	0.000606	0.00069	CcSEcCtD
Phenylephrine—Pruritus—Prednisone—multiple sclerosis	0.0006	0.000683	CcSEcCtD
Phenylephrine—Nausea—Dexamethasone—multiple sclerosis	0.000578	0.000659	CcSEcCtD
Phenylephrine—Nausea—Betamethasone—multiple sclerosis	0.000578	0.000659	CcSEcCtD
Phenylephrine—Urticaria—Methotrexate—multiple sclerosis	0.000563	0.000641	CcSEcCtD
Phenylephrine—Dizziness—Prednisone—multiple sclerosis	0.00056	0.000639	CcSEcCtD
Phenylephrine—Vomiting—Prednisone—multiple sclerosis	0.000539	0.000614	CcSEcCtD
Phenylephrine—Rash—Prednisone—multiple sclerosis	0.000534	0.000609	CcSEcCtD
Phenylephrine—Dermatitis—Prednisone—multiple sclerosis	0.000534	0.000608	CcSEcCtD
Phenylephrine—Headache—Prednisone—multiple sclerosis	0.000531	0.000605	CcSEcCtD
Phenylephrine—Hypersensitivity—Methotrexate—multiple sclerosis	0.000522	0.000595	CcSEcCtD
Phenylephrine—Nausea—Prednisone—multiple sclerosis	0.000503	0.000574	CcSEcCtD
Phenylephrine—Pruritus—Methotrexate—multiple sclerosis	0.000501	0.000571	CcSEcCtD
Phenylephrine—Dizziness—Methotrexate—multiple sclerosis	0.000468	0.000534	CcSEcCtD
Phenylephrine—Vomiting—Methotrexate—multiple sclerosis	0.00045	0.000513	CcSEcCtD
Phenylephrine—Rash—Methotrexate—multiple sclerosis	0.000447	0.000509	CcSEcCtD
Phenylephrine—Dermatitis—Methotrexate—multiple sclerosis	0.000446	0.000508	CcSEcCtD
Phenylephrine—Headache—Methotrexate—multiple sclerosis	0.000444	0.000506	CcSEcCtD
Phenylephrine—Nausea—Methotrexate—multiple sclerosis	0.000421	0.000479	CcSEcCtD
Phenylephrine—ADRA1A—GPCR downstream signaling—RGS1—multiple sclerosis	0.000168	0.00177	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CCR2—multiple sclerosis	0.000166	0.00175	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TAGAP—multiple sclerosis	0.000165	0.00173	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCRs, Class A Rhodopsin-like—CCR5—multiple sclerosis	0.000164	0.00173	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CCR1—multiple sclerosis	0.000164	0.00173	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000164	0.00173	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—GPR65—multiple sclerosis	0.000163	0.00172	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—CCL5—multiple sclerosis	0.000161	0.0017	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—GPR65—multiple sclerosis	0.000159	0.00168	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000158	0.00167	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—LINGO1—multiple sclerosis	0.000158	0.00166	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL5—multiple sclerosis	0.000156	0.00164	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—CXCL10—multiple sclerosis	0.000155	0.00164	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	0.000155	0.00164	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	0.000155	0.00164	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CNR1—multiple sclerosis	0.000153	0.00162	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—RGS1—multiple sclerosis	0.000153	0.00161	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—MYC—multiple sclerosis	0.000151	0.00159	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TGFB1—multiple sclerosis	0.000151	0.00159	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000149	0.00157	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CCR1—multiple sclerosis	0.000149	0.00157	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CXCL13—multiple sclerosis	0.000149	0.00157	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000148	0.00156	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—MAPK1—multiple sclerosis	0.000148	0.00156	CbGpPWpGaD
Phenylephrine—ADRA1D—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000146	0.00154	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CCR1—multiple sclerosis	0.000146	0.00154	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCL13—multiple sclerosis	0.000146	0.00154	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—CCR5—multiple sclerosis	0.000145	0.00153	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—GPR65—multiple sclerosis	0.000145	0.00152	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—S1PR1—multiple sclerosis	0.000144	0.00152	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—TNF—multiple sclerosis	0.000144	0.00151	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—RRM1—multiple sclerosis	0.000142	0.0015	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor—TNF—multiple sclerosis	0.000141	0.00148	CbGpPWpGaD
Phenylephrine—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—multiple sclerosis	0.000141	0.00148	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCR5—multiple sclerosis	0.000141	0.00148	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—LINGO1—multiple sclerosis	0.00014	0.00147	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GPC5—multiple sclerosis	0.00014	0.00147	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CXCL10—multiple sclerosis	0.000138	0.00145	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TAGAP—multiple sclerosis	0.000137	0.00144	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000136	0.00143	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—CCL5—multiple sclerosis	0.000134	0.00141	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CCR1—multiple sclerosis	0.000132	0.00139	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCL13—multiple sclerosis	0.000132	0.00139	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—TYK2—multiple sclerosis	0.000132	0.00139	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000131	0.00138	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CCL3—multiple sclerosis	0.000128	0.00135	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CCR2—multiple sclerosis	0.000127	0.00134	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.000124	0.0013	CbGpPWpGaD
Phenylephrine—MAOA—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	0.000124	0.0013	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—PTGER4—multiple sclerosis	0.000123	0.0013	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—RGS1—multiple sclerosis	0.000122	0.00129	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TAGAP—multiple sclerosis	0.000121	0.00128	CbGpPWpGaD
Phenylephrine—ADRA1B—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000121	0.00128	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—CCR5—multiple sclerosis	0.000121	0.00127	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—S1PR1—multiple sclerosis	0.000119	0.00126	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CXCR3—multiple sclerosis	0.000119	0.00125	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CCL5—multiple sclerosis	0.000119	0.00125	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CNR1—multiple sclerosis	0.000118	0.00124	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GPC5—multiple sclerosis	0.000116	0.00122	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—GPR65—multiple sclerosis	0.000116	0.00122	CbGpPWpGaD
Phenylephrine—MAOA—SIDS Susceptibility Pathways—IL6—multiple sclerosis	0.000116	0.00122	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CCR2—multiple sclerosis	0.000116	0.00122	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	0.000114	0.0012	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—POMC—multiple sclerosis	0.000114	0.0012	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—PTGER4—multiple sclerosis	0.000113	0.00119	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR ligand binding—CCL2—multiple sclerosis	0.000111	0.00117	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—POMC—multiple sclerosis	0.00011	0.00116	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CXCR3—multiple sclerosis	0.000109	0.00115	CbGpPWpGaD
Phenylephrine—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CCL2—multiple sclerosis	0.000108	0.00113	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CCR5—multiple sclerosis	0.000107	0.00113	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CNR1—multiple sclerosis	0.000107	0.00112	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CCL3—multiple sclerosis	0.000106	0.00112	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—S1PR1—multiple sclerosis	0.000106	0.00112	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCR1—multiple sclerosis	0.000106	0.00112	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCL13—multiple sclerosis	0.000106	0.00112	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CXCL10—multiple sclerosis	0.000106	0.00112	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CCR2—multiple sclerosis	0.000106	0.00111	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GPC5—multiple sclerosis	0.000103	0.00109	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—PTGER4—multiple sclerosis	0.000102	0.00108	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—RGS1—multiple sclerosis	0.000102	0.00107	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—PTGER4—multiple sclerosis	0.0001	0.00105	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CXCR3—multiple sclerosis	9.87e-05	0.00104	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—SRM—multiple sclerosis	9.82e-05	0.00103	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CNR1—multiple sclerosis	9.76e-05	0.00103	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCR3—multiple sclerosis	9.66e-05	0.00102	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—GPR65—multiple sclerosis	9.63e-05	0.00101	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CXCL10—multiple sclerosis	9.61e-05	0.00101	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CCR2—multiple sclerosis	9.6e-05	0.00101	CbGpPWpGaD
Phenylephrine—MAOA—Neuronal System—MAPK1—multiple sclerosis	9.48e-05	0.000998	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	9.45e-05	0.000996	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CCL3—multiple sclerosis	9.43e-05	0.000993	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—POMC—multiple sclerosis	9.42e-05	0.000993	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CCR2—multiple sclerosis	9.39e-05	0.000989	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR ligand binding—CCL2—multiple sclerosis	9.22e-05	0.000971	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CCL5—multiple sclerosis	9.11e-05	0.00096	CbGpPWpGaD
Phenylephrine—CYP1A2—Biological oxidations—POMC—multiple sclerosis	9.1e-05	0.000959	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—PTGER4—multiple sclerosis	9.08e-05	0.000956	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—RGS1—multiple sclerosis	9.02e-05	0.00095	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CNR1—multiple sclerosis	8.86e-05	0.000933	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCR1—multiple sclerosis	8.8e-05	0.000927	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCL13—multiple sclerosis	8.8e-05	0.000927	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CXCL10—multiple sclerosis	8.79e-05	0.000926	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCR3—multiple sclerosis	8.77e-05	0.000924	CbGpPWpGaD
Phenylephrine—ADRA1D—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	8.75e-05	0.000922	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CNR1—multiple sclerosis	8.67e-05	0.000913	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—GPR65—multiple sclerosis	8.55e-05	0.000901	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CCR2—multiple sclerosis	8.53e-05	0.000898	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—multiple sclerosis	8.4e-05	0.000884	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—POMC—multiple sclerosis	8.37e-05	0.000882	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CCL5—multiple sclerosis	8.28e-05	0.000872	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—CCR5—multiple sclerosis	8.21e-05	0.000865	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR ligand binding—CCL2—multiple sclerosis	8.19e-05	0.000863	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—BCHE—multiple sclerosis	8.17e-05	0.00086	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—IL2RA—multiple sclerosis	8.09e-05	0.000852	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CXCL10—multiple sclerosis	7.98e-05	0.00084	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CNR1—multiple sclerosis	7.87e-05	0.000829	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCL13—multiple sclerosis	7.82e-05	0.000824	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCR1—multiple sclerosis	7.82e-05	0.000824	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CXCL10—multiple sclerosis	7.81e-05	0.000822	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CCL5—multiple sclerosis	7.56e-05	0.000797	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCL3—multiple sclerosis	7.56e-05	0.000796	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CCR5—multiple sclerosis	7.46e-05	0.000785	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL2RA—multiple sclerosis	7.35e-05	0.000774	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PTGER4—multiple sclerosis	7.28e-05	0.000766	CbGpPWpGaD
Phenylephrine—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	7.26e-05	0.000765	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—PGR—multiple sclerosis	7.16e-05	0.000755	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CXCL10—multiple sclerosis	7.09e-05	0.000747	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCR3—multiple sclerosis	7.03e-05	0.00074	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CD28—multiple sclerosis	6.96e-05	0.000733	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP27B1—multiple sclerosis	6.92e-05	0.000729	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—CYP24A1—multiple sclerosis	6.92e-05	0.000729	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CCL5—multiple sclerosis	6.87e-05	0.000723	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCR2—multiple sclerosis	6.84e-05	0.00072	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—CCR5—multiple sclerosis	6.81e-05	0.000718	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	6.76e-05	0.000712	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CCL5—multiple sclerosis	6.72e-05	0.000708	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—IL2RA—multiple sclerosis	6.72e-05	0.000707	CbGpPWpGaD
Phenylephrine—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—multiple sclerosis	6.45e-05	0.000679	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—POMC—multiple sclerosis	6.42e-05	0.000676	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—GPC5—multiple sclerosis	6.33e-05	0.000667	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CNR1—multiple sclerosis	6.31e-05	0.000664	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL3—multiple sclerosis	6.27e-05	0.000661	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CCR5—multiple sclerosis	6.19e-05	0.000652	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CCL5—multiple sclerosis	6.1e-05	0.000643	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL2RA—multiple sclerosis	6.1e-05	0.000642	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—CCR5—multiple sclerosis	6.05e-05	0.000638	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PTGER4—multiple sclerosis	6.04e-05	0.000636	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—IL2RA—multiple sclerosis	5.97e-05	0.000628	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—PGR—multiple sclerosis	5.95e-05	0.000626	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCR3—multiple sclerosis	5.83e-05	0.000614	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—POMC—multiple sclerosis	5.83e-05	0.000614	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CD28—multiple sclerosis	5.78e-05	0.000608	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—CCL2—multiple sclerosis	5.7e-05	0.000601	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CXCL10—multiple sclerosis	5.68e-05	0.000598	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCR2—multiple sclerosis	5.67e-05	0.000598	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL3—multiple sclerosis	5.57e-05	0.000587	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CCR5—multiple sclerosis	5.5e-05	0.000579	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL2RA—multiple sclerosis	5.42e-05	0.000571	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PTGER4—multiple sclerosis	5.36e-05	0.000565	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—POMC—multiple sclerosis	5.33e-05	0.000561	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—PGR—multiple sclerosis	5.28e-05	0.000556	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—RRM1—multiple sclerosis	5.24e-05	0.000552	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CNR1—multiple sclerosis	5.24e-05	0.000551	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCR3—multiple sclerosis	5.18e-05	0.000546	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—TYK2—multiple sclerosis	5.18e-05	0.000545	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CD28—multiple sclerosis	5.13e-05	0.00054	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCR2—multiple sclerosis	5.04e-05	0.000531	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CD86—multiple sclerosis	4.97e-05	0.000523	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—APOE—multiple sclerosis	4.91e-05	0.000518	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCL5—multiple sclerosis	4.89e-05	0.000515	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—POMC—multiple sclerosis	4.84e-05	0.000509	CbGpPWpGaD
Phenylephrine—ADRA1D—GPCR downstream signaling—IL2—multiple sclerosis	4.74e-05	0.0005	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—CCL2—multiple sclerosis	4.73e-05	0.000498	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—POMC—multiple sclerosis	4.73e-05	0.000498	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CXCL10—multiple sclerosis	4.71e-05	0.000497	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CNR1—multiple sclerosis	4.65e-05	0.00049	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—SPP1—multiple sclerosis	4.53e-05	0.000477	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCR5—multiple sclerosis	4.4e-05	0.000464	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL2RA—multiple sclerosis	4.34e-05	0.000457	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL2—multiple sclerosis	4.31e-05	0.000454	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—TYK2—multiple sclerosis	4.3e-05	0.000453	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—POMC—multiple sclerosis	4.3e-05	0.000452	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—POMC—multiple sclerosis	4.22e-05	0.000445	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—CCL2—multiple sclerosis	4.2e-05	0.000443	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CXCL10—multiple sclerosis	4.19e-05	0.000441	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CD86—multiple sclerosis	4.12e-05	0.000434	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	4.07e-05	0.000429	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL5—multiple sclerosis	4.06e-05	0.000427	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—APOE—multiple sclerosis	4.01e-05	0.000422	CbGpPWpGaD
Phenylephrine—ADRA1B—GPCR downstream signaling—IL2—multiple sclerosis	3.94e-05	0.000415	CbGpPWpGaD
Phenylephrine—MAOA—Metabolism—ALB—multiple sclerosis	3.85e-05	0.000405	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—TYK2—multiple sclerosis	3.82e-05	0.000402	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—SPP1—multiple sclerosis	3.76e-05	0.000396	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CD86—multiple sclerosis	3.66e-05	0.000386	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCR5—multiple sclerosis	3.66e-05	0.000385	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CD80—multiple sclerosis	3.62e-05	0.000382	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL5—multiple sclerosis	3.6e-05	0.00038	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL2RA—multiple sclerosis	3.6e-05	0.000379	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL2—multiple sclerosis	3.58e-05	0.000377	CbGpPWpGaD
Phenylephrine—ADRA1A—GPCR downstream signaling—IL2—multiple sclerosis	3.5e-05	0.000368	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	3.5e-05	0.000368	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—POMC—multiple sclerosis	3.44e-05	0.000363	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—CCL2—multiple sclerosis	3.37e-05	0.000355	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—SPP1—multiple sclerosis	3.34e-05	0.000352	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—APOE—multiple sclerosis	3.33e-05	0.00035	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—MAPK1—multiple sclerosis	3.3e-05	0.000347	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCR5—multiple sclerosis	3.25e-05	0.000342	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL2RA—multiple sclerosis	3.2e-05	0.000337	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	3.19e-05	0.000336	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL2—multiple sclerosis	3.18e-05	0.000335	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TYK2—multiple sclerosis	3.06e-05	0.000322	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—BCHE—multiple sclerosis	3.01e-05	0.000317	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CD80—multiple sclerosis	3.01e-05	0.000317	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—APOE—multiple sclerosis	2.95e-05	0.000311	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—POMC—multiple sclerosis	2.86e-05	0.000301	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—CCL2—multiple sclerosis	2.8e-05	0.000294	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—MAPK1—multiple sclerosis	2.74e-05	0.000288	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CD80—multiple sclerosis	2.67e-05	0.000281	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL2—multiple sclerosis	2.54e-05	0.000268	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TYK2—multiple sclerosis	2.54e-05	0.000267	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—POMC—multiple sclerosis	2.54e-05	0.000267	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling by GPCR—IL6—multiple sclerosis	2.53e-05	0.000267	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—CCL2—multiple sclerosis	2.48e-05	0.000262	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—MAPK1—multiple sclerosis	2.43e-05	0.000256	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MMP9—multiple sclerosis	2.41e-05	0.000254	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TYK2—multiple sclerosis	2.25e-05	0.000237	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—STAT3—multiple sclerosis	2.14e-05	0.000226	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL2—multiple sclerosis	2.11e-05	0.000222	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling by GPCR—IL6—multiple sclerosis	2.1e-05	0.000221	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MMP9—multiple sclerosis	2e-05	0.000211	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MYC—multiple sclerosis	1.99e-05	0.00021	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—TGFB1—multiple sclerosis	1.99e-05	0.000209	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—MAPK1—multiple sclerosis	1.95e-05	0.000205	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL2—multiple sclerosis	1.88e-05	0.000198	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling by GPCR—IL6—multiple sclerosis	1.87e-05	0.000197	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—APOE—multiple sclerosis	1.81e-05	0.000191	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—STAT3—multiple sclerosis	1.78e-05	0.000187	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MMP9—multiple sclerosis	1.78e-05	0.000187	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MYC—multiple sclerosis	1.65e-05	0.000174	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—TGFB1—multiple sclerosis	1.65e-05	0.000174	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—MAPK1—multiple sclerosis	1.62e-05	0.00017	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—STAT3—multiple sclerosis	1.58e-05	0.000166	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—POMC—multiple sclerosis	1.56e-05	0.000164	CbGpPWpGaD
Phenylephrine—ADRA1D—Signaling Pathways—IL6—multiple sclerosis	1.5e-05	0.000158	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MYC—multiple sclerosis	1.47e-05	0.000155	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—TGFB1—multiple sclerosis	1.46e-05	0.000154	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—MAPK1—multiple sclerosis	1.44e-05	0.000151	CbGpPWpGaD
Phenylephrine—CYP1A2—Metabolism—ALB—multiple sclerosis	1.42e-05	0.000149	CbGpPWpGaD
Phenylephrine—ADRA1B—Signaling Pathways—IL6—multiple sclerosis	1.24e-05	0.000131	CbGpPWpGaD
Phenylephrine—ADRA1A—Signaling Pathways—IL6—multiple sclerosis	1.1e-05	0.000116	CbGpPWpGaD
